Gw Pharma ADR (GWPH)
$113.57 0.00 (0.00%)
8:00 EST GWPH Stock Quote Delayed 15 Minutes
Previous Close $113.57
Market Cap 3.20B
PE Ratio -
Volume (Avg. Vol.) 130
Day's Range 113.57 - 113.57
52-Week Range 95.71 - 196.00
Dividend & Yield N/A (N/A)
GWPH Stock Predictions, Articles, and Gw Pharma ADR News
- From InvestorPlace
- From the Web
A portfolio should hold high-risk, high-reward plays. And these nine stocks to buy offer big risks and even bigger potential returns.
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
Uber, Match Group, Kirkland Lake Gold, Humana and GW Pharma were our top stock trades from Wednesday. Let's look at the charts.
GW stock has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked cannabis stock.
These stocks to buy base at least some of their revenue on CBD and are poised to buck the downtrend that has hit the larger cannabis stocks.
Tilray, Canopy Growth and Cara Therapeutics are just a handful of cannabis stocks with the potential to double in value in the foreseeable future.
Looking for the real gains among the marijuana stocks? The key is to focus on firms using cannabis in medicine. Here are three biotech stocks moving headfirst into cannabis medicine.
Admittedly, GWPH stock could go either way before earnings. The sector in general has suffered amid falling prices for dried cannabis. With valuations still elevated, GWPH may need to offer a “perfect” report to keep the stock price from falling.
Zynerba landed a new patent for its Zygel product to use cannabidiol as a treatment for Autism Spectrum Disorder, sending ZYNE stock ripping.
Despite May's large losses, these stocks to buy made new 52-week highs. Maybe this is a signal that they will continue to head higher.
The CBD trend is heating up as its multiple uses gain traction and laws enable its use. Here are seven marijuana stocks to buy.
This week started strong for GW Pharmaceuticals, as management continues to deliver on promises, so GWPH stock should continue to deliver profits.
GW Pharmaceuticals (GWPH) reported its latest quarterly earnings results after hours today, bringing in sales that surged more than 1200%.
Medical cannabis’ cheap costs and natural uses will benefit GW Pharmaceuticals stock in the long run, keeping GWPH stock growing.
The ETFMG Alternative Harvest (MJ) ETF enables investors to take advantage of long-term trends in marijuana stocks.
GW Pharmaceutical reported its quarterly earnings results late on Tuesday, bringing in revenue that was thrice the amount it was a year ago.
With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.
From Simply Wall St
Every investor in GW Pharmaceuticals plc (NASDAQ:GWPH) should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it’s not unusual to see<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gwph/gw-pharmaceuticals/news/how-much-of-gw-pharmaceuticals-plc-nasdaqgwph-do-institutions-own/">Read More...</a></div>
From Market News Video
Investors in GW Pharmaceuticals plc (GWPH) saw new options become available this week, for the March 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GWPH options chain for the new March 20th contracts and identified one put and one call contract of particular interest.
Navellier RatingsPowered by Portfolio Grader